Catalyst Wire Dossier Catalyst Wire Dossier

Albendazole

ALBENDAZOLE · Alembic Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

55 regulatory and trial events tracked for Albendazole, covering 2006-11-07 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole [Phase 3]

See pricing